echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Ann Rheum Dis: Characteristics associated with COVID-19 hospitalization in patients with rheumatism

    Ann Rheum Dis: Characteristics associated with COVID-19 hospitalization in patients with rheumatism

    • Last Update: 2020-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    Little is known about the outcome of COVID-19 infection in patients with rheumatismThe purpose of this study was to analyze the demographic and clinical studies associated with COVID-19 hospitalization in patients with rheumatismFactorsSelect a series of cases of patients with COVID-19 infection from the COVID-19 Global Rheumatology Alliance register: 24 March 2020 to 20 April 2020ORs and 95% CIs were estimated in hospital using multifactorlogistic regressionAge, sex, smoking status, rheumatism diagnosis, comorbidities and rheumatism medications taken before infection were analyzedIncluded 600 cases from 40 countriesNearly half of the cases were hospitalized (277, 46 per cent) and 55 (9 per cent) diedIn the multi-factor adjustment model, the dose of pernisone of 10 mg/day was associated with an increased chance of hospitalization (OR 2.05, 95% CI 1.06-3.96)Use only conventional disease-improving anti-rheumatic drugs (DMARD) or combinations with biologic/Janus kinase inhibitors is not associated with hospitalization (OR 1.23, 95% CI 0.70-2.17 and OR 0.74, 95% CI 0.37-1.46)The use of nonsteroidal anti-inflammatory drugs is not related to hospitalization status (OR 0.64, 95% CI 0.39-1.06)The use of tumor necrosis factor inhibitors (anti-TNF) is associated with a reduced chance of hospitalization (OR 0.40, 95% CI 0.19-0.81) and not with the use of antimalarial drugs (OR 0.94, 95% CI 0.57-1.57)The study found that in patients with rheumatism, glucocorticoids of 10 mg/day were associated with an increased risk of hospitalization, while anti-TNF was associated with a decrease in the number of hospitalizationsBoth DMARDs and NSAIDs were not associated with an increased chance of hospitalization
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.